U.S. FDA approves Wegovy pill for weight loss

U.S. regulators connected Monday (December 22, 2025) gave the greenish airy to a pill mentation of the blockbuster weight-loss cause Wegovy, the archetypal regular oral medicine to dainty obesity.

The U.S. Food and Drug Administration’s support handed drugmaker Novo Nordisk an borderline implicit rival Eli Lilly successful the contention to marketplace an obesity pill. Lilly’s oral drug, orforglipron, is inactive nether review.

Both pills are GLP-1 drugs that enactment similar wide utilized injectables to mimic a earthy hormone that controls appetite and feelings of fullness.

In caller years, Novo Nordisk’s injectable Wegovy and Lilly’s Zepbound person revolutionised obesity attraction globally and successful the U.S., wherever 100 cardinal radical person the chronic disease.

Available wrong weeks

The Wegovy pills are expected to beryllium disposable wrong weeks, institution officials said. Availability of oral pills to dainty obesity could grow the booming marketplace for obesity treatments by broadening entree and reducing costs, experts said.

About 1 successful 8 Americans person utilized injectable GLP-1 drugs, according to a survey from KFF, a nonprofit wellness argumentation probe group. But galore much person occupation affording the costly shots.

“There’s an full demographic that tin payment from the pills,” said Dr. Fatima Cody Stanford, a Massachusetts General Hospital obesity expert. “For me, it’s not conscionable astir who gets it crossed the decorativeness enactment first. It’s astir having these options disposable to patients.”

The Novo Nordisk obesity pill contains 25 milligrams of semaglutide. That's the aforesaid constituent successful injectables Wegovy and Ozempic and successful Rybelsus, a lower-dose pill approved to dainty diabetes successful 2019.

Clinical trials

In a objective trial, participants who took oral Wegovy mislaid 13.6% of their full assemblage value connected mean implicit astir 15 months, compared with a 2.2% nonaccomplishment if they took a placebo, oregon dummy pill. That’s astir the aforesaid arsenic injectable Wegovy, with an mean value nonaccomplishment of astir 15%.

Chris Mertens, 35, a pediatric lung doc successful Menomonee Falls, Wisconsin, joined the Novo Nordisk proceedings successful 2022 and mislaid astir 40 pounds utilizing the Wegovy pill. The regular medicine worked to alteration his appetite and invasive thoughts of food, helium said.

“If determination were days wherever I missed a meal, I astir didn’t recognize it,” Dr. Mertens said.

Participants successful a objective proceedings who took the highest dose of Lilly’s orforglipron mislaid 11.2% of their full assemblage value connected mean implicit astir 17 months, compared with a 2.1% nonaccomplishment successful those who took a placebo.

Both pills resulted successful little value nonaccomplishment than the mean achieved with Lilly’s Zepbound, oregon tirzepatide, which targets 2 gut hormones, GLP-1 and GIP, and led to a 21% mean value loss.

Dosage directions

All the GLP-1 drugs, oral oregon injectable, person akin broadside effects, including nausea and diarrhea.

Both regular pills committedness convenience, but the Wegovy pill indispensable beryllium taken with a sip of h2o successful the greeting connected an bare stomach, with a 30-minute interruption earlier eating oregon drinking.

That’s due to the fact that Novo Nordisk had to plan the pill successful a mode that prevented the cause from being breached down successful the tummy earlier it could beryllium absorbed by the bloodstream. The drugmaker added an constituent that protects the medicine for astir 30 minutes successful the gut and makes it easier to instrumentality effect.

By contrast, Lilly’s orforglipron has nary dosing restrictions. That cause is being considered nether the FDA’s caller precedence voucher programme aimed astatine cutting cause support times. A determination is expected by spring.

‘All astir the price’

Producing pills is mostly cheaper than making drugs delivered via injections, truthful the outgo for the caller oral medications could beryllium lower. The Trump medication earlier this twelvemonth said officials had worked with drugmakers to negociate little prices for the GLP-1 drugs, which tin outgo upwards of $1,000 a month.

The institution said the starting dose would beryllium disposable for $149 per period from immoderate providers. Additional accusation connected outgo volition beryllium disposable successful January.

It’s not wide whether regular pills oregon play injections volition beryllium preferred by patients. Although immoderate patients dislike needles, others don't look to caput the play injections, obesity experts said. Mertens turned to injectable Zepbound erstwhile helium regained value aft the extremity of the Wegovy pill objective trial.

He said helium liked the subject of the regular pill.

“It was a small spot of an intentional regular and a reminder of contiguous I’m taking this truthful that I cognize my choices are going to beryllium affected for the day,” helium said.

Dr. Angela Fitch, an obesity adept and main aesculapian serviceman of knownwell, a wellness attraction company, said immoderate the format, the biggest payment volition beryllium successful making weight-loss medications much wide accessible and affordable.

“It’s each astir the price,” she said. “Just springiness maine a cause astatine $100 a period that is comparatively effective.”